Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Early DEtection of wEaring off in Parkinson disease: the DEEP study.

Stocchi F, Antonini A, Barone P, Tinazzi M, Zappia M, Onofrj M, Ruggieri S, Morgante L, Bonuccelli U, Lopiano L, Pramstaller P, Albanese A, Attar M, Posocco V, Colombo D, Abbruzzese G; DEEP study group.

Parkinsonism Relat Disord. 2014 Feb;20(2):204-11. doi: 10.1016/j.parkreldis.2013.10.027. Epub 2013 Nov 5. Erratum in: Parkinsonism Relat Disord. 2015 Jul;21(7):827.

PMID:
24275586
2.

The "gender factor" in wearing-off among patients with Parkinson's disease: a post hoc analysis of DEEP study.

Colombo D, Abbruzzese G, Antonini A, Barone P, Bellia G, Franconi F, Simoni L, Attar M, Zagni E, Haggiag S, Stocchi F.

ScientificWorldJournal. 2015;2015:787451. doi: 10.1155/2015/787451. Epub 2015 Jan 20.

3.

Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease.

Abbruzzese G, Antonini A, Barone P, Stocchi F, Tamburini T, Bernardi L, Amboni M, Vacca L, Posocco V, Colombo D.

Neurol Sci. 2012 Dec;33(6):1319-27. doi: 10.1007/s10072-012-0943-y. Epub 2012 Feb 4.

PMID:
22307444
4.

Wearing-off detection in clinical practice: the wearing off real practice key (WORK-PD) study in Parkinson's disease.

Altavista MC, Cassetta E, Brusa L, Viselli F, Denaro A, Ventriglia M, Pasqualetti P, Peppe A.

Parkinsonism Relat Disord. 2015 Feb;21(2):95-100. doi: 10.1016/j.parkreldis.2014.11.002. Epub 2014 Nov 14.

PMID:
25443558
5.

Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson's disease?

Bareš M, Rektorová I, Jech R, Farníková K, Roth J, Růžička E, Kaňovský P, Rektor I, Pavlík T, Uhlířová L, Vydlák J.

J Neural Transm (Vienna). 2012 Mar;119(3):373-80. doi: 10.1007/s00702-011-0683-9. Epub 2011 Jul 17.

PMID:
21769622
6.
7.

Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.

Stacy M, Bowron A, Guttman M, Hauser R, Hughes K, Larsen JP, LeWitt P, Oertel W, Quinn N, Sethi K, Stocchi F.

Mov Disord. 2005 Jun;20(6):726-33.

PMID:
15719426
8.

Naturalistic evaluation of entacapone in patients with signs and symptoms of L-dopa wearing-off .

Jog M, Panisset M, Suchowersky O, Réhel B, Schecter R.

Curr Med Res Opin. 2008 Nov;24(11):3207-15. doi: 10.1185/03007990802430518 . Epub 2008 Oct 14.

PMID:
18922214
9.

The sensitivity and specificity of the 9-item Wearing-off Questionnaire.

Stacy MA, Murphy JM, Greeley DR, Stewart RM, Murck H, Meng X; COMPASS-I Study Investigators.

Parkinsonism Relat Disord. 2008;14(3):205-12. Epub 2007 Sep 27.

PMID:
17900967
10.

A validation study of the Chinese wearing off questionnaire 9-symptom for Parkinson's disease.

Chan A, Cheung YF, Yeung MA, Yeung J, Chung TH, Tsang KL, Chan J, Lau C, Kwan P, Kuo SH, Mok V.

Clin Neurol Neurosurg. 2011 Sep;113(7):538-40. doi: 10.1016/j.clineuro.2011.03.007. Epub 2011 Apr 20.

PMID:
21507565
11.

End-of-dose wearing off in Parkinson disease: a 9-question survey assessment.

Stacy M, Hauser R, Oertel W, Schapira A, Sethi K, Stocchi F, Tolosa E.

Clin Neuropharmacol. 2006 Nov-Dec;29(6):312-21.

PMID:
17095894
12.

Utility of the Japanese version of the 9-item Wearing-off Questionnaire.

Fukae J, Higuchi MA, Yanamoto S, Fukuhara K, Tsugawa J, Ouma S, Hatano T, Yoritaka A, Okuma Y, Kashihara K, Hattori N, Tsuboi Y.

Clin Neurol Neurosurg. 2015 Jul;134:110-5. doi: 10.1016/j.clineuro.2015.04.021. Epub 2015 May 5.

PMID:
25985062
13.

[Direct switch from conventional levodopa to stalevo (levodopa/carbidopa/entacapone) improves quality of life in Parkinson's disease: results of an open-label clinical study].

Litvinenko IV, Odinak MM, Mogil'naia VI, Sologub OS, Sakharovskaia AA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(1):51-4. Russian.

PMID:
19156087
14.

A hospital-based study: risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy.

Benbir G, Ozekmekçi S, Apaydin H, Delil S, Erginöz E.

Clin Neurol Neurosurg. 2006 Dec;108(8):726-32. Epub 2006 Mar 27.

PMID:
16564615
15.

[Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].

Jost WH, Klasser M, Reichmann H.

Fortschr Neurol Psychiatr. 2008 Oct;76(10):594-9. doi: 10.1055/s-2008-1038249. Epub 2008 Oct 2. German.

PMID:
18833504
16.

Risk factors and safe dosage of levodopa for wearing-off phenomenon in Chinese patients with Parkinson's disease.

Chen H, Fang J, Li F, Gao L, Feng T.

Neurol Sci. 2015 Jul;36(7):1217-23. doi: 10.1007/s10072-015-2078-4. Epub 2015 Jan 24.

PMID:
25616444
17.

The wearing-off phenomenon and the use of questionnaires to facilitate its recognition in Parkinson's disease.

Stacy M.

J Neural Transm (Vienna). 2010 Jul;117(7):837-46. doi: 10.1007/s00702-010-0424-5. Epub 2010 Jun 20. Review.

PMID:
20563826
18.
19.

Sex differences in Parkinson's disease.

Lubomski M, Louise Rushworth R, Lee W, Bertram KL, Williams DR.

J Clin Neurosci. 2014 Sep;21(9):1503-6. doi: 10.1016/j.jocn.2013.12.016. Epub 2014 Apr 24.

PMID:
24767694
20.

Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson's disease.

Stacy M, Hauser R.

J Neural Transm (Vienna). 2007 Feb;114(2):211-7. Epub 2006 Aug 10.

PMID:
16897594
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk